Symmetry Partners’s Pediatrix Medical MD Stock Holding History

Symmetry Partners’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,715	Closed	-$57K	–	432
2018 Q4	$57K	Buy	+1,715	New	+$69K	0.01%	355

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Symmetry Partners's MD Position: Q1 2019 in Review

Symmetry Partners sold out of Pediatrix Medical (MD) in Q1 2019, closing a stake of 1,715 shares — an estimated $57K sold.

Symmetry Partners first reported a position in MD in Q4 2018 and held it in 1 quarter. The position peaked at $57K in Q4 2018. 297 funds tracked by Wall St. Rank hold MD as of Q1 2019.

Symmetry Partners reported no remaining Pediatrix Medical position as of Q1 2019 after selling out during the quarter.
Symmetry Partners sold 1,715 Pediatrix Medical shares in Q1 2019, an estimated $57K.
Symmetry Partners first reported a position in Pediatrix Medical in Q4 2018 and held it in 1 quarter.
Symmetry Partners's Pediatrix Medical position peaked at $57K in Q4 2018.
297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2019.

Based on Symmetry Partners's 13F filing for Q1 2019, filed 13 May 2019.